🗞️ How To Protect Qualified Health Centers Amid Threats To 340B 🗞️
View in browser ([link removed] )
LinkedIn ([link removed] )
YouTube ([link removed] )
Facebook ([link removed] )
X ([link removed] )
Instagram ([link removed] )
Website ([link removed] )
Monday, July 15, 2024 | The Latest Research, Commentary, and News from Health Affairs
Dear John,
Join us next Tuesday, July 23, for a Health Affairs Journal Club meeting with author Kathleen L. Miller discussing the US Food and Drug Administration’s breakthrough therapy designation (BTD) program.
This event is exclusive to our Health Affairs Insiders.
Become an Insider today ([link removed] ) to stay up-to-date on what health care experts are thinking and talking about.
Save The Date
([link removed] )
Today's Featured Articles
From the Journal: FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time ([link removed] )
Kathleen L. Miller et al.
Forefront: Protecting Federally Qualified Health Centers Amid Drugstore Closures And Threats To 340B ([link removed] )
Callie A. Gu et al.
Forefront: Nursing Home Trade Associations Challenge Administration’s New Staffing Requirements ([link removed] )
Sheela Ranganathan
More on Pharmaceuticals
- Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies ([link removed] ) by Caroline Horrow and Aaron S. Kesselheim
- Characteristics Of Key Patents Covering Recent FDA-Approved Drugs ([link removed] ) by Victor L. Van de Wiele et al.
- A Health Podyssey: Mariana Socal on the Global Supply Chain for Generic Drugs ([link removed] )
The Chevron Deference is Dead. What Now? w/ Andrew Twinamatsiko ([link removed] )
Health Affairs' Jeff Byers welcomes Andrew Twinamatsiko of the O'Neill Institute for National and Global Health Law back to the program to discuss the Supreme Court's recent overturning of the Chevron doctrine and the implications for health policy moving forward.
Listen
([link removed] )
HA_Scholar_1st-year_2024_eNewsletter-banner (1) ([link removed] )
Health Affairs Scholar ([link removed] ) is celebrating its one-year anniversary.
The digital journal published its first issue in July 2023 with a dedication to emerging policy trends and global health.
Its presence is growing. Cited by Congress and national media outlets like the New York Times, NPR, and the Los Angeles Times, Scholar has published papers on health care costs, access, quality, and equity. High-impact papers have included:
- Active steps to reduce administrative spending associated with financial transactions in US health care ([link removed] )
- Food and Drug Administration novel drug decisions in 2017: transparency and disclosure prior to and 5 years following approval ([link removed] )
- Has the fall of Roe changed contraceptive access and use? New research from four US states offers critical insights ([link removed] )
Read about Scholar’s first year from Editor-in-Chief Kathryn Phillips on Forefront ([link removed] ) .
health-affairs-43-07-order-issue_eNewsletter-banner ([link removed] )
LinkedIn ([link removed] )
YouTube ([link removed] )
Facebook ([link removed] )
X ([link removed] )
Instagram ([link removed] )
Website ([link removed] )
About Health Affairs
Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.
Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.
Project HOPE ([link removed] ) is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Privacy Policy ([link removed] )
Health Affairs, 1220 19th St. NW, Suite 800, Washington, DC 20036, United States, 202-408-6801
Manage preferences ([link removed] )
